Search results
Author(s):
Kerry Layne
,
Albert Ferro
Added:
3 years ago
Acute coronary syndrome (ACS) is a term used to encompass unstable angina (UA) and myocardial infarction (MI) with or without electrocardiographic (ECG) evidence of ST-segment elevation. Antiplatelet therapy has formed the backbone of ACS management for decades and the drug class continues to evolve as novel agents with increasingly efficacious antiplatelet actions are identified. The main risk…
View more
Author(s):
Syed Khurram Mushtaq Gardezi
Added:
3 years ago
Today, in cardiology, acute coronary syndrome (ACS) is one of the most common presentations in hospitals. Usually, the history and presenting features of ACS are very typical. However, some patients have an atypical presentation, which can pose a problem for prompt diagnosis and management, leading to an overall increase in morbidity and mortality in such patients.
Case Presentation
A 61-year…
View more
Author(s):
Deepak L Bhatt
Added:
5 years ago
Deepak Bhatt discusses the ODYSSEY Outcomes trial - alirocumab in patients after acute coronary syndrome.
Filmed by Radcliffe Cardiology on-site at the American College of Cardiology congress 2018 in Orlando, USA
View more
Neuroendocrine System Regulatory Mechanisms: Acute Coronary Syndrome and Stress Hyperglycaemia
Author(s):
Ricardo A Perez de la Hoz
,
Sandra Patricia Swieszkowski
,
Federico Matias Cintora
,
et al
Added:
3 years ago
Article
Author(s):
Masahiro Natsuaki
Added:
7 months ago
ESC 23 — Dr Masahiro Natsuaki (Saga University, JP) discusses the short and optimal duration of dual antiplatelet therapy-3 Study (STOPDAPT-3) (NCT04609111).
In the STOPDAPT-2 study, 1-month dual antiplatelet therapy (DAPT) followed by clopidogrel monotherapy was shown to provide benefits in bleeding reduction over a 12-month period, however, other trials have shown high rates of bleeding at…
View more
Author(s):
G Torres-Ruiz
,
P Rojas-Flores
,
P Carrion Montaner
,
et al
Added:
11 months ago
Author(s):
Christian Mueller
,
Evangelos Giannitsis
,
James L Januzzi
Added:
3 years ago
Improvements in the Early Diagnosis of Acute Myocardial Infarction using a Cardiac Troponin T-high Sensitive Assay
In the first talk, Christian Mueller, a Professor at the University Hospital in Basel, discussed the unmet needs of current troponin assays and the improvements made in the early diagnosis of acute myocardial infarction (AMI) using the latest cardiac troponin T-high sensitive (cTnT…
View more
Author(s):
Debasish Banerjee
,
Charlotte Perrett
,
Anita Banerjee
Added:
3 years ago
The development of increasingly sensitive and specific serum cardiac biomarkers has led a revolution in the diagnosis and management of acute coronary syndrome (ACS). However, although the troponins now in use are considered highly sensitive cardiac biomarkers in the general population, the interpretation of troponins in patients with acute kidney injury (AKI), chronic kidney disease (CKD) and…
View more
Author(s):
A Denegri
,
L Raeber
,
S Windecker
,
et al
Added:
3 years ago
Background: Although antidepressant therapy has been related to increased cardiovascular risk, depression, and its adverse effects on prognosis, is a well-recognised entity among acute coronary syndrome (ACS) patients. The aim of the study was to evaluate prevalence and outcome of antidepressant treatment in a real-world cohort of ACS patients.
Methods: We sought to assess the prevalence of…
View more